Zemdri (plazomicin)
NDC 80735-820, Plazomicin, injection, from Cipla Therapeutics Inc..
- Product NDC
- 80735-820
- Status
- Listed
- Labeler
- Cipla Therapeutics Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA210303
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/80735-820 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PLAZOMICIN500 mg/10mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 80735-820-96 | 80735082096 | 10 VIAL in 1 CARTON (80735-820-96) / 10 mL in 1 VIAL (80735-820-37) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1243fcd3-de84-428b-901e-d83d65e4d98cMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=80735-820
Use it
Look up 80735-820 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/80735-820 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 80735-820. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.